Cargando…

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

IMPORTANCE: Chiral switching, a strategy in which drug manufacturers develop a single-enantiomer formulation of a drug to be substituted for a racemic formulation, allows manufacturers to maintain market exclusivity for drugs losing patent protection, even without demonstrating superior efficacy or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Aaron S., Zhang, Audrey D., Meyer, Caitlin E., Egilman, Alexander C., Ross, Joseph S., Wallach, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103227/ https://www.ncbi.nlm.nih.gov/pubmed/33956134 http://dx.doi.org/10.1001/jamanetworkopen.2021.5731

Ejemplares similares

Comparative efficacy of esomeprazole and omeprazole: Racemate to single enantiomer switch
por: Asghar, Waheed, et al.
Publicado: (2015)

Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017
por: Skydel, Joshua J., et al.
Publicado: (2022)

Comparative single dose pharmacokinetics and metabolism of racemic primaquine and its enantiomers in human volunteers
por: Khan, Washim, et al.
Publicado: (2022)

Strategies for chiral separation: from racemate to enantiomer
por: Sui, Jingchen, et al.
Publicado: (2023)

A comparative Analysis of In Vitro and In Vivo Efficacies of the Enantiomers of Thioridazine and Its Racemate
por: Christensen, Jørn B., et al.
Publicado: (2013)

Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration
por: Egilman, Alexander, et al.
Publicado: (2021)

Comparative metabolism and tolerability of racemic primaquine and its enantiomers in human volunteers during 7-day administration
por: Khan, Washim, et al.
Publicado: (2023)

Pressure Dependence of the Crystallization Rate for the S-Enantiomer and a Racemic Mixture of Ibuprofen
por: Koperwas, Kajetan, et al.
Publicado: (2021)

Systematic overview of Freedom of Information Act requests to the Department of Health and Human Services from 2008 to 2017
por: Egilman, Alexander C., et al.
Publicado: (2019)

Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
por: Skydel, Joshua J., et al.
Publicado: (2019)

Racemization-free synthesis of Nα-2-thiophenoyl-phenylalanine-2-morpholinoanilide enantiomers and their antimycobacterial activity
por: Mann, Lea, et al.
Publicado: (2021)

Rotaxanes with dynamic mechanical chirality: Systematic studies on synthesis, enantiomer separation, racemization, and chiral-prochiral interconversion
por: Ishiwari, Fumitaka, et al.
Publicado: (2022)

High-Pressure Crystallization and Thermodynamic Stability Study on the Resolution of High-Density Enantiomers from Low-Density Racemates
por: Roszak, Kinga, et al.
Publicado: (2023)

Biomedical journal speed and efficiency: a cross-sectional pilot survey of author experiences
por: Wallach, Joshua D., et al.
Publicado: (2018)

Antipsychotic Benzamides Amisulpride and LB-102 Display Polypharmacy as Racemates, S Enantiomers Engage Receptors D(2) and D(3), while R Enantiomers Engage 5-HT(7)
por: Grattan, Vincent, et al.
Publicado: (2019)

Racemic Salsolinol and its Enantiomers Act as Agonists of the μ-Opioid Receptor by Activating the Gi Protein-Adenylate Cyclase Pathway
por: Berríos-Cárcamo, Pablo, et al.
Publicado: (2017)

Impact of enantiomer‐specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysis
por: Cloesmeijer, Michael E., et al.
Publicado: (2020)

Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020
por: Zhang, Audrey D., et al.
Publicado: (2021)

Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
por: Miller, Jennifer E., et al.
Publicado: (2021)

Evaluation of confounding in epidemiologic studies assessing alcohol consumption on the risk of ischemic heart disease
por: Wallach, Joshua D., et al.
Publicado: (2020)

Comparison of Clinical Study Results Reported in medRxiv Preprints vs Peer-reviewed Journal Articles
por: Janda, Guneet, et al.
Publicado: (2022)

Swim in the Chiral Pool: MDMA and MDA Enantiomers from Alanine-Derived Precursors
por: Sherwood, Alexander M., et al.
Publicado: (2023)

Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics
por: Varma, Tanvee, et al.
Publicado: (2021)

Conversion of Racemic Alkyl Aryl Sulfoxides into Pure Enantiomers Using a Recycle Photoreactor: Tandem Use of Chromatography on Chiral Support and Photoracemization on Solid Support
por: Tozawa, Kumi, et al.
Publicado: (2023)

Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice
por: Fasinu, Pius S., et al.
Publicado: (2022)

Cytotoxicity of enantiomers of gossypol.
por: Joseph, A. E., et al.
Publicado: (1986)

Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019
por: Dhodapkar, Meera, et al.
Publicado: (2021)

Disagreements Within the US Food and Drug Administration Regarding Approval of Novel Therapeutic Agents, 2011-2015
por: MacGregor, Andrea, et al.
Publicado: (2020)

Structural and Functional Characterization of the Enantiomers of the Antischistosomal Drug Oxamniquine
por: Taylor, Alexander B., et al.
Publicado: (2015)

Crystallographic and spectroscopic characterization of racemic Mosher’s Acid
por: Savich, Carolyn Z., et al.
Publicado: (2020)

Enantiopure nanohoops through racemic resolution of diketo[n]CPPs by chiral derivatization as precursors to DBP[n]CPPs
por: Wassy, Daniel, et al.
Publicado: (2021)

Palm Raceme as a Promising Biomass Precursor for Activated Carbon to Promote Lipase Activity with the Aid of Eutectic Solvents
por: Abed, Khalid M., et al.
Publicado: (2022)

Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017
por: Zhang, Audrey D., et al.
Publicado: (2020)

Single enantiomer synthesis of α-(trifluoromethyl)-β-lactam
por: Jurčík, Václav, et al.
Publicado: (2011)

The Pyrolysis of (−)-(S)-Nicotine: Racemization and Decomposition
por: Clayton, Peter, et al.
Publicado: (2010)

Optimizing the data available via Health Canada’s clinical information portal
por: Egilman, Alexander C., et al.
Publicado: (2021)

Optimiser les données accessibles dans le portail de renseignements cliniques de Santé Canada
por: Egilman, Alexander C., et al.
Publicado: (2021)

Chiroptical Properties and the Racemization of Pyrene and Tetrathiafulvalene-Substituted Allene: Substitution and Solvent Effects on Racemization in Tetrathiafulvalenylallene
por: Hasegawa, Masashi, et al.
Publicado: (2014)

Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021
por: Daval, C. Joseph Ross, et al.
Publicado: (2023)

Analysis of Enantiomers in Products of Food Interest
por: Fanali, Chiara, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m53cjkt1kghuie8qh6vb15lrtb